These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1299707)
1. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group. Jamet P; Ji B Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707 [TBL] [Abstract][Full Text] [Related]
2. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
3. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports. Thomas A; Hari L; Nagarajan M; Prabhakar R Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922 [TBL] [Abstract][Full Text] [Related]
4. Two microbiological relapses in a patient with lepromatous leprosy. Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984 [TBL] [Abstract][Full Text] [Related]
5. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281 [TBL] [Abstract][Full Text] [Related]
6. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low. Gelber RH; Balagon VF; Cellona RV Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209 [TBL] [Abstract][Full Text] [Related]
7. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy. Jamet P; Blanc L; Fayne OC; Traore I; Bobin P Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259 [TBL] [Abstract][Full Text] [Related]
8. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years. Norman G; Joseph G; Richard J Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321 [TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients. Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888 [TBL] [Abstract][Full Text] [Related]
10. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Vijayakumaran P; Manimozhi N; Jesudasan K Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714 [TBL] [Abstract][Full Text] [Related]
11. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group. Jamet P; Ji B Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):195-201. PubMed ID: 7602214 [TBL] [Abstract][Full Text] [Related]
12. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin. Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T; Kaur I; Kumar B; Radotra BD; Dogra S Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [TBL] [Abstract][Full Text] [Related]
14. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
15. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines. Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628 [TBL] [Abstract][Full Text] [Related]
16. Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. Grosset JH; Guelpa-Lauras CC; Bobin P; Brucker G; Cartel JL; Constant-Desportes M; Flageul B; Frédéric M; Guillaume JC; Millan J Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):607-14. PubMed ID: 2674301 [TBL] [Abstract][Full Text] [Related]
17. A case of relapse with drug-susceptible M. leprae after multidrug therapy. Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981 [TBL] [Abstract][Full Text] [Related]
19. New lesions after MDT in PB and MB leprosy: a report of 28 cases. Kar HK; Sharma P Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355 [TBL] [Abstract][Full Text] [Related]
20. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases. Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]